EP3806827A4 - Formulations de pulvérisation d'épinéphrine - Google Patents
Formulations de pulvérisation d'épinéphrine Download PDFInfo
- Publication number
- EP3806827A4 EP3806827A4 EP19819360.9A EP19819360A EP3806827A4 EP 3806827 A4 EP3806827 A4 EP 3806827A4 EP 19819360 A EP19819360 A EP 19819360A EP 3806827 A4 EP3806827 A4 EP 3806827A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- spray formulations
- epinephrine spray
- epinephrine
- formulations
- spray
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 title 1
- 229930182837 (R)-adrenaline Natural products 0.000 title 1
- 229960005139 epinephrine Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007921 spray Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/007,999 US11571384B2 (en) | 2015-09-18 | 2018-06-13 | Epinephrine spray formulations |
| US16/007,998 US11517525B2 (en) | 2015-09-18 | 2018-06-13 | Epinephrine spray formulations |
| US16/023,313 US10617637B2 (en) | 2015-09-18 | 2018-06-29 | Epinephrine spray formulations |
| US16/240,632 US10966925B2 (en) | 2015-09-18 | 2019-01-04 | Epinephrine spray formulations |
| US16/290,853 US10973781B2 (en) | 2015-09-18 | 2019-03-01 | Epinephrine spray formulations |
| PCT/US2019/036788 WO2019241401A1 (fr) | 2018-06-13 | 2019-06-12 | Formulations de pulvérisation d'épinéphrine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3806827A1 EP3806827A1 (fr) | 2021-04-21 |
| EP3806827A4 true EP3806827A4 (fr) | 2022-03-23 |
Family
ID=68842158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19819360.9A Pending EP3806827A4 (fr) | 2018-06-13 | 2019-06-12 | Formulations de pulvérisation d'épinéphrine |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3806827A4 (fr) |
| JP (1) | JP7443258B2 (fr) |
| CN (1) | CN112512506A (fr) |
| CA (1) | CA3102815A1 (fr) |
| WO (1) | WO2019241401A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3178769A1 (fr) | 2020-05-18 | 2021-11-25 | Jonas Savmarker | Nouvelle composition pharmaceutique pour une administration de medicament |
| AR127780A1 (es) | 2021-11-25 | 2024-02-28 | Orexo Ab | Nueva composición farmacéutica que comprende adrenalina |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170079907A1 (en) * | 2015-09-18 | 2017-03-23 | Insys Development Company, Inc. | Sublingual Epinephrine Spray |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69901936T2 (de) | 1998-01-30 | 2002-11-28 | Novartis Consumer Health Sa | Nasale lösungen |
| US9119876B1 (en) | 2015-03-13 | 2015-09-01 | Par Pharmaceutical, Inc. | Epinephrine formulations |
| US11517525B2 (en) * | 2015-09-18 | 2022-12-06 | Hikma Pharmaceuticals Usa Inc. | Epinephrine spray formulations |
| US10039710B2 (en) * | 2015-09-18 | 2018-08-07 | Insys Development Company, Inc. | Epinephrine spray formulations |
-
2019
- 2019-06-12 WO PCT/US2019/036788 patent/WO2019241401A1/fr unknown
- 2019-06-12 CN CN201980040116.9A patent/CN112512506A/zh active Pending
- 2019-06-12 CA CA3102815A patent/CA3102815A1/fr active Pending
- 2019-06-12 JP JP2020569019A patent/JP7443258B2/ja active Active
- 2019-06-12 EP EP19819360.9A patent/EP3806827A4/fr active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170079907A1 (en) * | 2015-09-18 | 2017-03-23 | Insys Development Company, Inc. | Sublingual Epinephrine Spray |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019241401A1 (fr) | 2019-12-19 |
| JP7443258B2 (ja) | 2024-03-05 |
| JP2021527091A (ja) | 2021-10-11 |
| CN112512506A (zh) | 2021-03-16 |
| EP3806827A1 (fr) | 2021-04-21 |
| CA3102815A1 (fr) | 2019-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3768250A4 (fr) | Formulations pour la pulvérisation d'épinéphrine | |
| EP3582755A4 (fr) | Préparations | |
| EP3600257B8 (fr) | Formulations de phosphatase alcaline | |
| EP3580321A4 (fr) | Compositions de nettoyage | |
| EP3612173A4 (fr) | Formulations pour la pulvérisation d'épinéphrine | |
| EP3758510A4 (fr) | Ingrédient | |
| EP3903886A4 (fr) | Produit cosmétique | |
| EP3817829A4 (fr) | Buse de pulvérisation à froid | |
| EP3960227A4 (fr) | Dispositif d'atomisation | |
| EP3766478A4 (fr) | Produit cosmétique | |
| EP3689999A4 (fr) | Pulvérisateur | |
| EP4018998A4 (fr) | Produit cosmétique | |
| EP3862291A4 (fr) | Atomiseur | |
| EP3806827A4 (fr) | Formulations de pulvérisation d'épinéphrine | |
| EP4007590A4 (fr) | Formulations comprenant du dihydrohonokiol | |
| EP3949801A4 (fr) | Ensemble cosmétique | |
| EP3881899A4 (fr) | Produit cosmétique | |
| EP3840848A4 (fr) | Ensemble extincteur automatique à sec | |
| EP3834079A4 (fr) | Configuration à réponses multiples et à questions multiples | |
| EP3755678A4 (fr) | Formulation d'un biostimulant | |
| EP3741465A4 (fr) | Unité de buse | |
| EP3582748A4 (fr) | Formulations sans sulfate | |
| EP4032573A4 (fr) | Atomiseur | |
| EP4013441A4 (fr) | Formulations de larazotide | |
| EP3831359A4 (fr) | Produit cosmétique de type aérosol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20210113 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: NARAYANAN, ESHWARAN Inventor name: INAVOLU, RACHANA Inventor name: CHILAMPALLI, CHANDESHWARI Inventor name: GOSKONDA, VENKAT Inventor name: YAN, NINGXIN Inventor name: BASTIAN, CRAIG Inventor name: POTTA, THRIMOORTHY |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20220221 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 37/08 20060101ALI20220215BHEP Ipc: A61K 47/12 20060101ALI20220215BHEP Ipc: A61K 9/12 20060101AFI20220215BHEP |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230513 |
|
| RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HIKMA PHARMACEUTICALS USA INC. |